198
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Neutrophil–Lymphocyte Ratio (NLR) for Predicting Clinical Outcomes in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus: A Propensity Score Matching Analysis

, &
Pages 437-443 | Published online: 19 May 2020

References

  • Rajabi M, Mansourian A, Pilesjo P, Astrom DO, Cederin K, Sundquist K. Exploring spatial patterns of cardiovascular disease in Sweden between 2000 and 2010. Scand J Public Health. 2018;46:647–658. doi:10.1177/1403494818780845
  • Rodriguez A, Pajukanta P. Genomics and systems biology approaches in the study of lipid disorders. Rev Invest Clin. 2018;70:217–223. doi:10.24875/RIC.18002576
  • Bowry AD, Lewey J, Dugani SB, Choudhry NK. The burden of cardiovascular disease in low- and middle-income countries: epidemiology and management. Can J Cardiol. 2015;31:1151–1159. doi:10.1016/j.cjca.2015.06.028
  • Ren YC, Liu Y, Sun XZ, et al. Prevalence and relationship of hypertriglyceridaemic-waist phenotype and type 2 diabetes mellitus among a rural adult Chinese population. Public Health Nutr. 2019;1–6.
  • Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6:69–80. doi:10.1016/S2213-8587(17)30186-9
  • Katsiki N, Purrello F, Tsioufis C, Mikhailidis DP. Cardiovascular disease prevention strategies for type 2 diabetes mellitus. Expert Opin Pharmacother. 2017;18:1243–1260. doi:10.1080/14656566.2017.1351946
  • Geiker NRW, Larsen ML, Dyerberg J, Stender S, Astrup A. Egg consumption, cardiovascular diseases and type 2 diabetes. Eur J Clin Nutr. 2018;72:44–56. doi:10.1038/ejcn.2017.153
  • Martin-Timon I, Sevillano-Collantes C, Segura-Galindo A, Del Canizo-Gomez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes. 2014;5:444–470. doi:10.4239/wjd.v5.i4.444
  • A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Diabetes mellitus: a major risk factor for cardiovascular disease. Circulation. 1999;100:1132–1133. doi:10.1161/01.cir.100.10.1132
  • Bravo PE, Psaty BM, Di Carli MF, Branch KR. Identification of coronary heart disease in asymptomatic individuals with diabetes mellitus: to screen or not to screen. Colomb Med (Cali). 2015;46:41–46.
  • Duman TT, Aktas G, Atak BM, Kocak MZ, Erkus E, Savli H. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19:1602–1606. doi:10.4314/ahs.v19i1.35
  • Sit M, Aktas G, Erkol H, Yaman S, Keyif F, Savli H. Neutrophil to lymphocyte ratio is useful in differentiation of Malign and Benign thyroid nodules. P R Health Sci J. 2019;38:60–63.
  • Aktas G, Sit M, Dikbas O, et al. Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto’s thyroiditis. Rev Assoc Med Bras. 2017;63:1065–1068. doi:10.1590/1806-9282.63.12.1065
  • Cho JH, Cho HJ, Lee HY, et al. Neutrophil-lymphocyte ratio in patients with acute heart failure predicts in-hospital and long-term mortality. J Clin Med. 2020;9. doi:10.3390/jcm9020557
  • Posul E, Yilmaz B, Aktas G, Kurt M. Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis? Wien Klin Wochenschr. 2015;127:262–265. doi:10.1007/s00508-014-0683-5
  • Abu Omar Y, Randhawa T, Attar B, et al. Prognostic value of neutrophil-lymphocyte ratio in patients with severe alcoholic hepatitis. Cureus. 2019;11:e6141.
  • Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10:12. doi:10.1186/s13104-016-2335-5
  • Ethier JL, Desautels D, Templeton A, Shah PS, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2017;19:2. doi:10.1186/s13058-016-0794-1
  • Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124. doi:10.1093/jnci/dju124
  • Xu T, Weng Z, Pei C, et al. The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in type 2 diabetes mellitus. Medicine (Baltimore). 2017;96:e8289. doi:10.1097/MD.0000000000008289
  • Liu S, Zheng H, Zhu X, et al. Neutrophil-to-lymphocyte ratio is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Res Clin Pract. 2017;130:90–97. doi:10.1016/j.diabres.2017.05.008
  • Li X, Shen J, Lu Z, Chen M, Fang X, Wang G. High neutrophil-to-lymphocyte ratio is associated with increased carotid artery intima-media thickness in type 2 diabetes. J Diabetes Investig. 2017;8:101–107. doi:10.1111/jdi.12541
  • Liu N, Sheng J, Pan T, Wang Y. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with lower extremity vascular lesions in Chinese patients with type 2 diabetes. Clin Lab. 2019;65.
  • Ye T, Yang Y, Wang K, et al. [Neutrophil to lymphocyte ratio as a predictor for type 2 diabetes mellitus in patients with chronic obstructive pulmonary disease: a cohort study of 404 cases]. Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:1308–1314. Chinese.
  • Yilmaz H, Ucan B, Sayki M, et al. Usefulness of the neutrophil-to-lymphocyte ratio to prediction of type 2 diabetes mellitus in morbid obesity. Diabetes Metab Syndr. 2015;9:299–304. doi:10.1016/j.dsx.2014.04.009
  • Hanley JA. Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging. 1989;29:307–335.
  • Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc. 1958;53:457–481. doi:10.1080/01621459.1958.10501452
  • Cox DR. Regression models and life-tables. J Royal Stat Soc B. 1972;34:187–220.
  • Malik M, Suboc TM, Tyagi S, et al. Lactobacillus plantarum 299v supplementation improves vascular endothelial function and reduces inflammatory biomarkers in men with stable coronary artery disease. Circ Res. 2018;123:1091–1102. doi:10.1161/CIRCRESAHA.118.313565
  • Tani S, Nagao K, Hirayama A. Association of systemic inflammation with the serum apolipoprotein A-1 level: a cross-sectional pilot study. J Cardiol. 2016;68:168–177. doi:10.1016/j.jjcc.2015.08.016
  • Rein P, Saely CH, Silbernagel G, et al. Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease. Atherosclerosis. 2015;239:299–303. doi:10.1016/j.atherosclerosis.2015.01.021
  • Johnson ES, Dickerson JF, Vollmer WM, et al. The feasibility of matching on a propensity score for acupuncture in a prospective cohort study of patients with chronic pain. BMC Med Res Methodol. 2017;17:42. doi:10.1186/s12874-017-0318-4
  • Baek S, Park SH, Won E, Park YR, Kim HJ. Propensity score matching: a conceptual review for radiology researchers. Korean J Radiol. 2015;16:286–296. doi:10.3348/kjr.2015.16.2.286
  • Penning de Vries BBL, Groenwold RHH. Cautionary note: propensity score matching does not account for bias due to censoring. Nephrol Dial Transplant. 2018;33:914–916. doi:10.1093/ndt/gfx198
  • Duhamel A, Labreuche J, Gronnier C, Mariette C. Statistical tools for propensity score matching. Ann Surg. 2017;265:E79–e80. doi:10.1097/SLA.0000000000001312
  • Desai RJ, Rothman KJ, Bateman BT, Hernandez-Diaz S, Huybrechts KF. A propensity-score-based fine stratification approach for confounding adjustment when exposure is infrequent. Epidemiology. 2017;28:249–257. doi:10.1097/EDE.0000000000000595
  • Andrade C. Propensity score matching in nonrandomized studies: a concept simply explained using antidepressant treatment during pregnancy as an example. J Clin Psychiatry. 2017;78:e162–e165. doi:10.4088/JCP.17f11446
  • Lin GN, Peng JW, Liu PP, Liu DY, Xiao JJ, Chen XQ. Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment. Asia Pac J Clin Oncol. 2017;13:e189–e194. doi:10.1111/ajco.12273
  • Go SI, Lee A, Lee US, et al. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer. Lung Cancer. 2014;84:79–85. doi:10.1016/j.lungcan.2014.01.014
  • He W, Yin C, Guo G, et al. Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol. 2013;30:439. doi:10.1007/s12032-012-0439-x
  • Kobayashi N, Usui S, Kikuchi S, et al. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer. 2012;75:223–227. doi:10.1016/j.lungcan.2011.06.009
  • Jung MR, Park YK, Jeong O, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol. 2011;104:504–510. doi:10.1002/jso.21986